MedPath
NMPA Approval

Fluticasone Propionate Nebuliser Suspension

国药准字HJ20170361

eddingpharm b.v.

January 11, 2022

H20170361

Drug Information

丙酸氟替卡松雾化吸入用混悬液

辅舒酮

雾化吸入用混悬液

2ml:0.5mg

化学药品

January 11, 2022

January 10, 2027

Company Information

Applicant Company

eddingpharm b.v.

Prins Bernhardplein 200, 1097 JB Amsterdam, The Netherlands

Manufacturing Company

1061 Mountain Highway BORONIA VIC 3155 AUSTRALIA

© Copyright 2025. All Rights Reserved by MedPath
丙酸氟替卡松雾化吸入用混悬液 - NMPA 批准文号 | MedPath